Curran Simpson
CIK 1346164 · Chief Executive Officer · last filed 2026-01-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.28M
Companies
2
Total Filings
62
Lifetime Open-Market Net
-$25.77M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Executive Officer | 342,467 | $6.66 | $2.28M | -$17.42M | 38 | 2026-01-08 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Sr. VP, Operations | 0 | — | — | -$8.35M | 24 | 2012-08-01 |
Recent Filings · Page 3 of 7
62 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-06 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | RGNX | Sell (S) | −15,552 | -$680.2K | EDGAR |
| 2019-05-30 | RGNX | Mixed | — | -$504.0K | EDGAR |
| 2019-02-27 | RGNX | Mixed | — | -$96.7K | EDGAR |
| 2019-02-07 | RGNX | Mixed | — | -$1.12M | EDGAR |
| 2019-01-07 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2018-11-20 | RGNX | Mixed | — | -$1.37M | EDGAR |
| 2018-10-18 | RGNX | Mixed | — | -$2.48M | EDGAR |
| 2018-03-15 | RGNX | Mixed | — | -$275.0K | EDGAR |
| 2018-01-05 | RGNX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.